[go: up one dir, main page]

PT77616A - Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same - Google Patents

Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same

Info

Publication number
PT77616A
PT77616A PT77616A PT7761683A PT77616A PT 77616 A PT77616 A PT 77616A PT 77616 A PT77616 A PT 77616A PT 7761683 A PT7761683 A PT 7761683A PT 77616 A PT77616 A PT 77616A
Authority
PT
Portugal
Prior art keywords
imidazolylalkylthien
dazines
tetrahydropyri
preparing
same
Prior art date
Application number
PT77616A
Other languages
English (en)
Other versions
PT77616B (en
Inventor
Gerd Hilboll
Gerrit Prop
Harald Borbe
Josef Peter Loehr
Ille-Stephanie Doppelfeld
Original Assignee
Nattermann A & Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nattermann A & Cie filed Critical Nattermann A & Cie
Publication of PT77616A publication Critical patent/PT77616A/pt
Publication of PT77616B publication Critical patent/PT77616B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT77616A 1982-11-06 1983-11-04 Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same PT77616B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823241102 DE3241102A1 (de) 1982-11-06 1982-11-06 Imidazolylalkylthienyl-tetrahydropyridazine und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
PT77616A true PT77616A (en) 1983-12-01
PT77616B PT77616B (en) 1986-03-19

Family

ID=6177509

Family Applications (1)

Application Number Title Priority Date Filing Date
PT77616A PT77616B (en) 1982-11-06 1983-11-04 Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same

Country Status (11)

Country Link
US (1) US4643998A (pt)
EP (1) EP0112987B1 (pt)
JP (1) JPS59108781A (pt)
AT (1) ATE26274T1 (pt)
DE (2) DE3241102A1 (pt)
DK (1) DK156660C (pt)
ES (1) ES8406472A1 (pt)
GR (1) GR78945B (pt)
IE (1) IE56127B1 (pt)
PT (1) PT77616B (pt)
ZA (1) ZA837976B (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3407509A1 (de) * 1984-03-01 1985-09-05 A. Nattermann & Cie GmbH, 5000 Köln Neue arzneimittelkombination zur behandlung von bluthochdruck und thromboembolischen erkrankungen
DE3606105A1 (de) * 1986-02-26 1987-08-27 Nattermann A & Cie Verfahren zur herstellung von imidazolyl-thiophenaldehyden
DE3626865A1 (de) * 1986-08-08 1988-02-11 Boehringer Mannheim Gmbh Neue pyridazinon-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
US5958926A (en) * 1996-11-01 1999-09-28 Nitromed, Inc. Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
US6518412B1 (en) * 1997-09-29 2003-02-11 Jean-Louis Dasseux Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) * 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6037323A (en) * 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6046166A (en) * 1997-09-29 2000-04-04 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US7217785B2 (en) * 2001-05-09 2007-05-15 The Regents Of The University Of California Cysteine-containing peptides having antioxidant properties
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
DE102004036075B3 (de) * 2004-07-24 2006-02-16 Bos Gmbh & Co. Kg Anordnung für Seitenfensterrollo
KR20080065704A (ko) 2005-11-09 2008-07-14 콤비네이토릭스, 인코포레이티드 의학적 이상의 치료 방법들, 조성물들, 및 키트들
US20100120694A1 (en) 2008-06-04 2010-05-13 Synergy Pharmaceuticals, Inc. Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
US7879802B2 (en) 2007-06-04 2011-02-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
MX357121B (es) 2011-03-01 2018-06-27 Synergy Pharmaceuticals Inc Star Proceso de preparacion de agonistas c de guanilato ciclasa.
WO2013097052A1 (en) 2011-12-30 2013-07-04 Abbott Laboratories Bromodomain inhibitors
WO2013106547A1 (en) 2012-01-10 2013-07-18 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
US9545446B2 (en) 2013-02-25 2017-01-17 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
CA2905438A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
EP3004138B1 (en) 2013-06-05 2024-03-13 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス，インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
EP3287453A1 (en) * 2015-04-24 2018-02-28 Medshine Discovery Inc. Imidazole compound
BR112018071216A2 (pt) 2016-04-15 2019-02-05 Abbvie Inc inibidores de bromodomínios
WO2018072702A1 (zh) * 2016-10-20 2018-04-26 南京明德新药研发股份有限公司 一种咪唑类化合物的晶型、盐型及其制备方法
US20200368223A1 (en) 2019-05-21 2020-11-26 Ardelyx, Inc. Methods for inhibiting phosphate transport

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3130252A1 (de) * 1981-07-31 1983-02-17 A. Nattermann & Cie GmbH, 5000 Köln 6-(5-((omega)-(1-imidazolyl)-alkyl)-thien-2-yl)-3-oxo-2,3,4,5-tetrahydro-pyridazine und deren saeureadditionssalze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
HU190412B (en) * 1981-09-17 1986-09-29 Warner-Lambert Co,Us Process for producing substituted 4,5-dihiydro-6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones and 6-bracket-substituted-bracket closed-phenyl-3-bracket-2h-bracket closed-pyridazinones
US4353905A (en) * 1981-09-17 1982-10-12 Warner-Lambert Company Substituted 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and 6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones

Also Published As

Publication number Publication date
DK156660C (da) 1990-03-05
DE3241102A1 (de) 1984-05-10
IE56127B1 (en) 1991-04-24
IE832484L (en) 1984-05-06
DE3370626D1 (en) 1987-05-07
DK505983D0 (da) 1983-11-04
ES527027A0 (es) 1984-07-01
ZA837976B (en) 1984-06-27
EP0112987A1 (de) 1984-07-11
DK156660B (da) 1989-09-18
GR78945B (pt) 1984-10-02
EP0112987B1 (de) 1987-04-01
ES8406472A1 (es) 1984-07-01
JPS59108781A (ja) 1984-06-23
PT77616B (en) 1986-03-19
DK505983A (da) 1984-05-07
JPH054391B2 (pt) 1993-01-19
US4643998A (en) 1987-02-17
ATE26274T1 (de) 1987-04-15

Similar Documents

Publication Publication Date Title
PT77616A (en) Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same
PT77125A (en) Process for preparing triphenylimidazolyloxy-alkanoic acids and their derivatives and of pharmaceutical compositions containing these compounds
ZA796651B (en) New amino-pyrimidine-carbanilides, processes for their preparation, medicaments containing these compounds and their use and also diamino-pyrimidinecarbanilides and processes for their preparation
HUT50842A (en) Process for producing new diphosphonic acid derivatives and pharmaceutical compositions comprising same
PT77344A (en) Process for the preparation of new diazabicyclo-3,3,1-nonanes
DE3378580D1 (en) Imidazolylphenyl-tetrahydropyridazines, process for their preparation and pharmaceutical compositions containing them
ZA84562B (en) 2-imino-pyrrolidines,process for their preparation,and therapeutic compositions containing same
DE3360669D1 (en) Halogenobenzhydrylsulfinylacetohydroxamic acids, preparation and therapeutical use
SE8404308L (sv) Polyprenylkarboxylsyraamider, forfarande for deras framstellning samt farmaceutiska kompositioner innehallande dessa foreningar
DE3371515D1 (en) Cycloalkyl derivatives of benzisoselenazolones, process for their preparation and pharmaceutical compositions containing them
EP0134179A3 (en) Derivatives of 4-phenyl-4-oxo-buten-2-oic acid, their preparation, their use as medicines and compositions containing them
CZ228195A3 (en) Derivatives of hydroxymethylfurazancarboxylic acid, process of their preparation, their use for treating cardiovascular diseases and a pharmaceutical composition containing thereof
DE3062340D1 (en) 1-n-alkylsisomicin derivatives, process for their preparation and their use as medicines
DE3277971D1 (en) Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use
ES8802612A1 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES8307778A1 (es) Procedimiento para preparar difenilbutil-1-piperazinocarboxilatos.
IE820118L (en) Anthranilic acid.
DE3060305D1 (en) Cyclophosphathiazenes, process for their preparation and compositions containing them
GR3015706T3 (en) Benzylselenobenzamides of aminopyridines and picolylamines.
EP0036991B1 (en) 5-alkyl-3-alkylthiopropionthioates, process for their preparation and their use as pharmaceutical compositions
ES8101579A1 (es) Procedimiento para la obtencion de un derivado del aldehido 3,4-dihidroxicinamico

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19920319